Literature DB >> 30651369

The Polar Region of the HIV-1 Envelope Protein Determines Viral Fusion and Infectivity by Stabilizing the gp120-gp41 Association.

Wuxun Lu1, Shuliang Chen1, Jingyou Yu1, Ryan Behrens2, Joshua Wiggins3, Nathan Sherer2, Shan-Lu Liu1,4, Yong Xiong5, Shi-Hua Xiang3, Li Wu6,4.   

Abstract

HIV-1 enters cells through binding between viral envelope glycoprotein (Env) and cellular receptors to initiate virus and cell fusion. HIV-1 Env precursor (gp160) is cleaved into two units noncovalently bound to form a trimer on virions, including a surface unit (gp120) and a transmembrane unit (gp41) responsible for virus binding and membrane fusion, respectively. The polar region (PR) at the N terminus of gp41 comprises 17 residues, including 7 polar amino acids. Previous studies suggested that the PR contributes to HIV-1 membrane fusion and infectivity; however, the precise role of the PR in Env-mediated viral entry and the underlying mechanisms remain unknown. Here, we show that the PR is critical for HIV-1 fusion and infectivity by stabilizing Env trimers. Through analyzing the PR sequences of 57,645 HIV-1 isolates, we performed targeted mutagenesis and functional studies of three highly conserved polar residues in the PR (S532P, T534A, and T536A) which have not been characterized previously. We found that single or combined mutations of these three residues abolished or significantly decreased HIV-1 infectivity without affecting viral production. These PR mutations abolished or significantly reduced HIV-1 fusion with target cells and also Env-mediated cell-cell fusion. Three PR mutations containing S532P substantially reduced gp120 and gp41 association, Env trimer stability, and increased gp120 shedding. Furthermore, S532A mutation significantly reduced HIV-1 infectivity and fusogenicity but not Env expression and cleavage. Our findings suggest that the PR of gp41, particularly the key residue S532, is structurally essential for maintaining HIV-1 Env trimer, viral fusogenicity, and infectivity.IMPORTANCE Although extensive studies of the transmembrane unit (gp41) of HIV-1 Env have led to a fusion inhibitor clinically used to block viral entry, the functions of different domains of gp41 in HIV-1 fusion and infectivity are not fully elucidated. The polar region (PR) of gp41 has been proposed to participate in HIV-1 membrane fusion in biochemical analyses, but its role in viral entry and infectivity remain unclear. In our effort to characterize three nucleotide mutations of an HIV-1 RNA element that partially overlaps the PR coding sequence, we identified a novel function of the PR that determines viral fusion and infectivity. We further demonstrated the structural and functional impact of six PR mutations on HIV-1 Env stability, viral fusion, and infectivity. Our findings reveal the previously unappreciated function of the PR and the underlying mechanisms, highlighting the important role of the PR in regulating HIV-1 fusion and infectivity.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  HIV-1; entry; envelope glycoprotein; fusion; gp160; gp41; infectivity; polar region; trimer

Mesh:

Substances:

Year:  2019        PMID: 30651369      PMCID: PMC6430531          DOI: 10.1128/JVI.02128-18

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  41 in total

1.  Sensitivity of human immunodeficiency virus type 1 to the fusion inhibitor T-20 is modulated by coreceptor specificity defined by the V3 loop of gp120.

Authors:  C A Derdeyn; J M Decker; J N Sfakianos; X Wu; W A O'Brien; L Ratner; J C Kappes; G M Shaw; E Hunter
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

2.  Role for the terminal clasp of HIV-1 gp41 glycoprotein in the initiation of membrane fusion.

Authors:  Chan-Sien Lay; Louise E Ludlow; David Stapleton; Anna K Bellamy-McIntyre; Paul A Ramsland; Heidi E Drummer; Pantelis Poumbourios
Journal:  J Biol Chem       Date:  2011-10-05       Impact factor: 5.157

3.  Amino acid propensities for secondary structures are influenced by the protein structural class.

Authors:  Susan Costantini; Giovanni Colonna; Angelo M Facchiano
Journal:  Biochem Biophys Res Commun       Date:  2006-02-08       Impact factor: 3.575

4.  SAMHD1 Impairs HIV-1 Gene Expression and Negatively Modulates Reactivation of Viral Latency in CD4+ T Cells.

Authors:  Jenna M Antonucci; Sun Hee Kim; Corine St Gelais; Serena Bonifati; Tai-Wei Li; Olga Buzovetsky; Kirsten M Knecht; Alice A Duchon; Yong Xiong; Karin Musier-Forsyth; Li Wu
Journal:  J Virol       Date:  2018-07-17       Impact factor: 5.103

5.  Nuclear Export Signal Masking Regulates HIV-1 Rev Trafficking and Viral RNA Nuclear Export.

Authors:  Ryan T Behrens; Mounavya Aligeti; Ginger M Pocock; Christina A Higgins; Nathan M Sherer
Journal:  J Virol       Date:  2017-01-18       Impact factor: 5.103

Review 6.  HIV-1 envelope glycoprotein biosynthesis, trafficking, and incorporation.

Authors:  Mary Ann Checkley; Benjamin G Luttge; Eric O Freed
Journal:  J Mol Biol       Date:  2011-07-22       Impact factor: 5.469

7.  The polar region consecutive to the HIV fusion peptide participates in membrane fusion.

Authors:  S G Peisajovich; R F Epand; M Pritsker; Y Shai; R M Epand
Journal:  Biochemistry       Date:  2000-02-22       Impact factor: 3.162

Review 8.  HIV: cell binding and entry.

Authors:  Craig B Wilen; John C Tilton; Robert W Doms
Journal:  Cold Spring Harb Perspect Med       Date:  2012-08-01       Impact factor: 6.915

9.  Crystal structure of HIV-1 gp41 including both fusion peptide and membrane proximal external regions.

Authors:  Victor Buzon; Ganesh Natrajan; David Schibli; Felix Campelo; Michael M Kozlov; Winfried Weissenhorn
Journal:  PLoS Pathog       Date:  2010-05-06       Impact factor: 6.823

10.  Epitope-based vaccine design yields fusion peptide-directed antibodies that neutralize diverse strains of HIV-1.

Authors:  Kai Xu; Priyamvada Acharya; Rui Kong; Cheng Cheng; Gwo-Yu Chuang; Kevin Liu; Mark K Louder; Sijy O'Dell; Reda Rawi; Mallika Sastry; Chen-Hsiang Shen; Baoshan Zhang; Tongqing Zhou; Mangaiarkarasi Asokan; Robert T Bailer; Michael Chambers; Xuejun Chen; Chang W Choi; Venkata P Dandey; Nicole A Doria-Rose; Aliaksandr Druz; Edward T Eng; S Katie Farney; Kathryn E Foulds; Hui Geng; Ivelin S Georgiev; Jason Gorman; Kurt R Hill; Alexander J Jafari; Young D Kwon; Yen-Ting Lai; Thomas Lemmin; Krisha McKee; Tiffany Y Ohr; Li Ou; Dongjun Peng; Ariana P Rowshan; Zizhang Sheng; John-Paul Todd; Yaroslav Tsybovsky; Elise G Viox; Yiran Wang; Hui Wei; Yongping Yang; Amy F Zhou; Rui Chen; Lu Yang; Diana G Scorpio; Adrian B McDermott; Lawrence Shapiro; Bridget Carragher; Clinton S Potter; John R Mascola; Peter D Kwong
Journal:  Nat Med       Date:  2018-06-04       Impact factor: 53.440

View more
  3 in total

1.  HIV Transmembrane Glycoprotein Conserved Domains and Genetic Markers Across HIV-1 and HIV-2 Variants.

Authors:  Ana Valadés-Alcaraz; Roberto Reinosa; África Holguín
Journal:  Front Microbiol       Date:  2022-05-27       Impact factor: 6.064

2.  Conserved Residue Asn-145 in the C-Terminal Heptad Repeat Region of HIV-1 gp41 is Critical for Viral Fusion and Regulates the Antiviral Activity of Fusion Inhibitors.

Authors:  Xiuzhu Geng; Zixuan Liu; Danwei Yu; Bo Qin; Yuanmei Zhu; Sheng Cui; Huihui Chong; Yuxian He
Journal:  Viruses       Date:  2019-07-03       Impact factor: 5.048

Review 3.  Updates on CRISPR-based gene editing in HIV-1/AIDS therapy.

Authors:  Zhihao Zhang; Wei Hou; Shuliang Chen
Journal:  Virol Sin       Date:  2022-01-19       Impact factor: 4.327

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.